ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +5.6% ·
flujo de acciones -2.5% ·
nuevas posiciones netas 0.0%
· fórmula
Fragmentación de la titularidad: más titulares, participación agregada más pequeña
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | -1 | 146.16M | $1.22B | +9 | −12 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | n/a |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | n/a | n/a |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | n/a |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | n/a | −2 |
| Q2 2024 | 13 | n/a | 23.97M | $268.00M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 35.63M | -2.3% | $522.36M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (pasivo) | 20.97M | -1.8% | $307.49M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasivo) | 13.56M | +12.3% | $198.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 5.81M | -1.7% | $85.24M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | Goldman Sachs Group ✦ | 2.91M | n/a | $42.67M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 6 | Renaissance Technologies ✦ | 2.77M | -11.9% | $40.61M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.16M | +0.8% | $31.60M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 2.12M | Nuevo | $31.07M | 0.0% | New | 1 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 1.46M | n/a | $21.38M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 10 | Point72 Asset Management ✦ | 1.32M | Nuevo | $19.38M | 0.0% | New | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 923.40K | n/a | $13.54M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | Two Sigma Investments ✦ | 898.03K | -25.3% | $13.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 732.66K | -77.2% | $10.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 14 | D. E. Shaw & Co. ✦ | 332.70K | -60.0% | $4.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Millennium Management ✦ | 284.84K | -74.9% | $4.18M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 275.16K | -40.2% | $4.03M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 17 | Wellington Management ✦ | 103.30K | -88.9% | $1.51M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 18 | Bridgewater Associates ✦ | 60.28K | Nuevo | $883,734 | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 11.01K | -89.9% | $161,421 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Citadel Advisors | $31.07M | 0.0% |
| Point72 Asset Management | $19.38M | 0.0% |
| Bridgewater Associates | $883,734 | 0.0% |
Posición cerrada
| Arrowstreet Capital | $6.57M | era 0.0% |
| Norges Bank | $548,722 | era 0.0% |
| Marshall Wace | $384,048 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 355 tenedores, 211.31M acciones, $1.84B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.